Anticancer activity of some polyamine derivatives on human prostate and breast cancer cell lines. 2017

Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
Department of Hospital Pharmacy, Faculty of Pharmacy, Medical University of Lodz, Łódź, Poland.

The aim of this study was to expand our knowledge about anticancer activity of some polyamine derivatives with quinoline or chromane as terminal moieties. Tested compounds were evaluated in vitro towards metastatic human prostate adenocarcinoma (PC3), human carcinoma (DU145) and mammary gland adenocarcinoma (MCF7) cell lines. Cell viability was estimated on the basis of mitochondrial metabolic activity using water-soluble tetrazolium WST1 to establish effective concentrations of the tested compounds under experimental conditions. Cytotoxic potential of polyamine derivatives was determined by the measurement of lactate dehydrogenase activity released from damaged cells, changes in mitochondrial membrane potential, the cell cycle distribution analysis and apoptosis assay. It was revealed that the tested polyamine derivatives differed markedly in their antiproliferative activity. Bischromane derivative 5a exhibited a rather cytostatic than cytotoxic effect on the tested cells, whereas quinoline derivative 3a caused changes in cell membrane integrity, inhibited cell cycle progression, as well as induced apoptosis of prostate and breast cancer cells which suggest its potential application in cancer therapy.

UI MeSH Term Description Entries
D008297 Male Males
D011073 Polyamines Amine compounds that consist of carbon chains or rings containing two or more primary amino groups. Polyamine
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D053078 Membrane Potential, Mitochondrial The voltage difference, normally maintained at approximately -180mV, across the INNER MITOCHONDRIAL MEMBRANE, by a net movement of positive charge across the membrane. It is a major component of the PROTON MOTIVE FORCE in MITOCHONDRIA used to drive the synthesis of ATP. Delta Psi M,DeltaPsi M,DeltapsiM,Mitochondrial Membrane Potential,Mitochondrial Transmembrane Potential,M, DeltaPsi,Membrane Potentials, Mitochondrial,Mitochondrial Membrane Potentials,Mitochondrial Transmembrane Potentials,Transmembrane Potential, Mitochondrial,Transmembrane Potentials, Mitochondrial

Related Publications

Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
September 2022, Chemico-biological interactions,
Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
March 2017, Breast cancer (Tokyo, Japan),
Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
August 2014, Molecules (Basel, Switzerland),
Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
January 2017, Iranian journal of pharmaceutical research : IJPR,
Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
March 2017, Integrative medicine research,
Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
April 2021, Asian Pacific journal of cancer prevention : APJCP,
Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
June 2006, Toxicology,
Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
May 2006, Bioorganic & medicinal chemistry,
Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
April 1993, Arzneimittel-Forschung,
Marta Szumilak, and Malgorzata Galdyszynska, and Kamila Dominska, and Andrzej Stanczak, and Agnieszka Piastowska-Ciesielska
June 1992, Arzneimittel-Forschung,
Copied contents to your clipboard!